Microbiology & infectious diseases

Fungi

Yeasts

Candida auris



Last author update: 7 November 2023
Last staff update: 7 November 2023

Copyright: 2019-2024, PathologyOutlines.com, Inc.

PubMed Search: Candida auris

Amaro Nunes Duarte-Neto, M.D., Ph.D.
Page views in 2023: 254
Page views in 2024 to date: 362
Cite this page: Duarte-Neto AN. Candida auris. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/microbiologycauris.html. Accessed April 25th, 2024.
Definition / general
Essential features
  • Candida auris has a similar morphology to other Candida species in infected tissues, except C. glabrata, which does not form pseudohyphae or hyphae (Mycoses 2018;61:377)
  • Incidence in the U.S. has been rising with outbreaks in healthcare facilities
ICD coding
  • ICD-10
    • B37 - candidiasis
    • B37.7 - candidal sepsis
    • B37.9 - candidiasis, unspecified
    • P37.5 - neonatal candidiasis
Epidemiology
  • Outbreaks of C. auris have happened in the U.S. since 2016, after the introduction of multiple strains from different continents; since then, local transmission has taken place (MMWR Morb Mortal Wkly Rep 2016;65:1234, Lancet Infect Dis 2018;18:1377)
  • Major outbreaks occurred in Illinois, Chicago, New York and New Jersey (MMWR Morb Mortal Wkly Rep 2020;69:6, Ann Intern Med 2021;174:1554)
  • Risks for C. auris infection include (MMWR Morb Mortal Wkly Rep 2017;66:514)
    • Immunosuppression (malignancy, chemotherapy, neutropenia, high doses of corticosteroids, AIDS, chronic underlying diseases)
    • Prolonged intensive care stays
    • Abdominal surgery and anastomotic leak
    • Pancreatitis
    • Hemodialysis
    • Use of broad spectrum antibiotics and azoles (previous fluconazole treatment)
    • Total parenteral nutrition
    • Injection of illicit drugs
  • Preventive measures for healthcare infection transmission, such as contact isolation for colonized or infected patients and laboratory diagnostic surveillance to determine species and antifungal susceptibility / resistance in Candida isolates (MMWR Morb Mortal Wkly Rep 2017;66:514)
Sites
  • Candida auris can infect any organ from any body system
  • Bloodstream and disseminated infection must be investigated when C. auris is isolated from any sample (Clin Microbiol Rev 2017;31:e00029)
Pathophysiology
  • Candida auris infection starts with colonization, followed by tissue invasion and then reaches the bloodstream
  • Candida auris forms biofilm on catheter device surfaces (insertion or hub)
    • Total parenteral nutrition is rich in lipid emulsions, which enhances the biofilm formation; broad spectrum antibiotics and intestinal / biliary surgery alter normal flora with Candida spp. overgrowth, predisposing to its intestinal translocation, followed by bloodstream dissemination
  • Host factors predispose to disseminated C. auris infections (e.g., immune dysfunction [neutropenia, lymphopenia, denutrition, etc.] and mucositis after chemotherapy) (Clin Microbiol Rev 2017;31:e00029)
Etiology
  • Retrospective study has shown the first Candida auris isolate is from South Korea
  • Sequencing of internal transcribed spacer (ITS) and D1 / D2 regions of ribosomal DNA has shown C. auris is similar to C. haemulonii and C. pseudohaemulonii in < 88% and 85%, respectively
  • C. auris is geographically grouped into 4 clades: East Asia, South Asia, Africa and South America
  • Molecular profiles of sequenced strains are more linked with strains from the same country (Clin Microbiol Rev 2017;31:e00029)
Clinical features
  • Invasive healthcare associated infections with high mortality
  • Pneumonia
  • Vascular device associated bloodstream infections
  • Skin lesions (papules, ulcers) in disseminated disease
  • Pyelonephritis
  • Biliary tract infections
  • Inhospital sepsis
  • Septic shock
  • Panophthalmitis in immunocompromised host (AIDS) (Am J Ophthalmol Case Rep 2020;19:100738)
Diagnosis
  • Definitive diagnosis of C. auris infection is performed with sequencing of 18S ITS regions or D1 / D2 regions of ribosomal DNA
  • Real time polymerase chain reaction (RT PCR) may have high diagnostic accuracy
  • Proteomic methods, such as MALDI TOF MS, can be useful
  • Significant overlap with other Candida species on cultures, phenotypic and biochemical diagnostic systems (Clin Microbiol Rev 2017;31:e00029)
Laboratory
  • Patients with C. auris infection may have neutropenia, anemia, lymphopenia, elevated C reactive protein or signs of multiorgan system failure with altered markers for organ dysfunction (azotemia, hypoxemia, elevated bilirubin, etc.) (Clin Microbiol Rev 2017;31:e00029)
Radiology description
  • Nonspecific
    • Abscesses, pneumonia, pyelonephritis
    • Infective foci suggestive of hematogenous spread
Radiology images

Images hosted on other servers:
Candida auris pneumonia

Candida auris pneumonia

Candida auris encephalitis

Candida auris encephalitis

Prognostic factors
  • Candida auris infection has a poor prognosis in general
Case reports
Treatment
  • Echinocandins
    • C. auris has a higher minimum inhibitory concentration (MIC) than other Candida species
  • Lipid formulation amphotericin (Clin Microbiol Rev 2017;31:e00029)
  • Often multidrug resistant
Gross description
Microscopic (histologic) description
  • Spores, pseudohyphae and hyphae (Mycoses 2018;61:377, Clin Microbiol Rev 2011;24:247)
    • Yeasts measure 3 - 5 μm in diameter
    • Candida auris has a similar morphology to other Candida species in infected tissues, except C. glabrata, which does not form pseudohyphae or hyphae
    • Yeasts measure without capsule and with narrow neck budding
    • Hyphae with erratic ramification (in general, < 45°) and absence of septa
  • Tissue inflammatory reaction: variable, depending on host immune status; in general, necrosis, cell debris and mixed inflammatory reaction, with neutrophils, microabscesses
  • Invasion of mucosa and vessels (angioinvasion); Candida invasive form: hyphae (Emerg Microbes Infect 2020;9:1160)
  • Colonization of mucosa (mucosal surface, amid mucous, fibrinous exudate and cell debris), without epithelial invasion (Emerg Microbes Infect 2020;9:1160)
Microscopic (histologic) images

Contributed by Amaro Nunes Duarte-Neto, M.D., Ph.D.
Candida auris and inflammatory cells Candida auris and inflammatory cells Candida auris and inflammatory cells

Candida auris and inflammatory cells

Cytology description
  • Round to ovoid, isolated or grouped cells on smear; this method is not species specific and cannot differentiate colonization from invasive infection
Cytology images

Images hosted on other servers:
Culture and microscopic images of C. auris

Culture and microscopic images of C. auris

Positive stains
Negative stains
Electron microscopy description
Electron microscopy images

Images hosted on other servers:
Candida albicans chlamydospore

Candida albicans chlamydospore

Yeast cells ultrastructure

Yeast cells ultrastructure

Molecular / cytogenetics description
  • Multiplex PCR setup using specific primers for glycosylphosphatidylinositol (GPI) protein encoding genes; it is applicable for fluids and fresh tissue samples (Int J Med Microbiol 2018;308:812)
Sample pathology report
  • Any tissue, biopsy or autopsy:
    • Candida infection (see comment)
    • Comment: The fungal structures show yeasts, pseudohyphae and hyphae forms, with single narrow neck budding, with (or without) angioinvasion.
Differential diagnosis
  • Cryptococcus spp. (Clin Microbiol Rev 2011;24:247):
    • Measure 4 - 10 μm in diameter
    • May form germinative tube in highly proliferative infections
    • Small yeasts in small tissue samples (e.g., pulmonary biopsies) may not produce a large capsule or mucopolysaccharide, rendering the diagnosis difficult
    • Fontana-Masson stain may be helpful (stain melanin on Cryptococcus capsule)
  • Histoplasma capsulatum (Clin Microbiol Rev 2011;24:247):
    • Small yeasts (measure 2 - 4 μm in diameter) in small samples can be problematic for diagnosis
    • Histoplasma spp. may have a central black dot on the Grocott stain
    • Thick pseudocapsule on H&E may be helpful
  • Malassezia furfur (Clin Microbiol Rev 2011;24:247):
    • Fungic structures with spaghetti and meatball appearance on the stratum corneum of the skin
  • Hyphomycetes (Clin Microbiol Rev 2011;24:247):
    • Wide hyphae with spores and pseudohyphae
    • Isolated conidia of Aspergillus in small lung biopsies may be difficult when it is not possible to identify Aspergillus conidial heads; those conidias are amphophilic on H&E, Grocott positive, PAS positive and gram positive, mimicking Candida spp. spores, mainly C. glabrata
Board review style question #1

A premature newborn (33 weeks of pregnancy) was hospitalized in the intensive care unit after birth with a low Apgar score and respiratory insufficiency. He was maintained on mechanical ventilation; central venous lines were set and he was fed with a nasogastric tube. On the eighth day, he developed abdominal distension, had bloody stool and was diagnosed with necrotizing colitis, which required large spectrum antibiotics and surgical treatment. He was then started on total parenteral nutrition. After a week, the newborn developed a new sepsis with alveolar - perivascular infiltrates on the lungs. A bronchoalveolar lavage showed mixed inflammatory infiltrate surrounding structures, which are shown in the image above. What is the most likely etiological agent of this sepsis?

  1. Aspergillus spp.
  2. Candida spp.
  3. Gram positive cocci
  4. Histoplasma capsulatum
Board review style answer #1
B. Candida spp. There are spores, pseudohyphae and hyphae in the figure. Candida spp. are the most common nosocomial fungal infections and their main characteristic is forming spore, pseudohyphae and hyphae in tissues. Answer D is incorrect because H. capsulatum is a yeast in tissue and rarely produces pseudohyphae, even in cases with high fungal burden; moreover, it is not a common fungal nosocomial infection. Answer C is incorrect because gram positive cocci do not have a yeast-like aspect in tissues, as they are much smaller, without budding. Gram positive cocci form colonies in tissues. Answer A is incorrect because Aspergillus spp. are hyaline hyphae fungal agents, with acute dichotomous branching and multiple regular septa. Candida spp. can form hyphae but they are associated with spores and pseudohyphae. The Candida spp. hyphae are amphiphilic, randomly branching and without septa.

Comment Here

Reference: Candida auris
Board review style question #2
A man with idiopathic pulmonary fibrosis requiring high dose corticosteroids was hospitalized with fever and sepsis. The blood culture identified Candida spp. and in a few days, the strain was identified as C. auris by sequencing the D1 / D2 region of the 28s ribosomal DNA. In parallel, the patient developed bilateral pulmonary infiltrates with respiratory insufficiency and was put under mechanical ventilation. A bronchoalveolar lavage and biopsy were performed, showing round to oval yeasts, with thick walls and narrow based single budding, associated with mononuclear inflammatory reaction. Rare forms showed germinative tubes. Which stain should be requested to confirm the etiology of this fungal infection?

  1. Gram stain
  2. Mucicarmine stain
  3. Von Kossa stain
  4. Ziehl-Neelsen stain
Board review style answer #2
B. Mucicarmine stain. Cryptococcus spp. has mucicarmine positive capsule. It causes opportunistic infections in patients who receive high doses of corticoids, mainly pneumonia and meningitis. Cryptococcosis can occur with other opportunistic infections in the same patient. When there is high C. neoformans tissue burden, some yeasts can form germ tubes, which mimic Candida spp. pseudohyphae. Answer A is incorrect because Gram stain can label all fungal species (as they are all gram positive) and does not give a specific diagnosis. Answers C and D are incorrect because these stains (von Kossa and Ziehl-Neelsen) do not stain fungal forms.

Comment Here

Reference: Candida auris
Back to top
Image 01 Image 02